跳至主要内容
临床试验/ACTRN12621001673831
ACTRN12621001673831进行中(未招募)未知

Clinical effectiveness and cost-effectiveness of a multicomponent frailty management program Say No To Frailty” in Singapore for adults over 65: A Cluster-randomized controlled trial

Singapore Institute of Technology0 个研究点目标入组 116 人开始时间: 2021年12月7日最近更新:
适应症

试验速览

阶段
未知
状态
进行中(未招募)
入组人数
116

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Educational / counselling / training
盲法
Blinded (masking used)

入排标准

年龄范围
65 Years 至 o limit(—)
性别
All

入选标准

  • - Age 65 years old or above
  • - Live at home or in the community
  • - Able to communicate verbally and understand instructions
  • - Able to walk with/without a walking aid for a short distance independently
  • - Signs of frailty (e.g. muscle weakness, reduced balance and mobility, loss of weight) with Clinical Frailty Scale (CFS) scored between 4 and 6
  • - No severe cognitive impairment (Abbreviated Mental Test score >5)*
  • *Clients with mild cognitive impairment is eligible to join this program; however, he/she must be accompanied by a caregiver during the group sessions.

排除标准

  • - Absence of frailty or pre-frailty
  • - Diagnosed with dementia or AMT scores 5 or lower.
  • - Inability to walk independently without the help of another person or wheelchair-bound
  • - Recent cardiac arrest or any unstable medical conditions

研究者

相似试验

Testing the effectiveness of a multicomponent... | 临床试验